These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 18410795

  • 1. Preclinical investigations with epothilones in breast cancer models.
    Burris HA.
    Semin Oncol; 2008 Apr; 35(2 Suppl 2):S15-21; quiz S39. PubMed ID: 18410795
    [Abstract] [Full Text] [Related]

  • 2. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
    Cortes J, Baselga J.
    Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
    [Abstract] [Full Text] [Related]

  • 3. Clinical studies with epothilones for the treatment of metastatic breast cancer.
    Vahdat LT.
    Semin Oncol; 2008 Apr; 35(2 Suppl 2):S22-30; quiz S40. PubMed ID: 18410796
    [Abstract] [Full Text] [Related]

  • 4. Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms.
    Vahdat L.
    Oncologist; 2008 Mar; 13(3):214-21. PubMed ID: 18378531
    [Abstract] [Full Text] [Related]

  • 5. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY, Borzilleri R, Fairchild CR, Kamath A, Smykla R, Kramer R, Vite G.
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [Abstract] [Full Text] [Related]

  • 6. Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.
    Trivedi M, Budihardjo I, Loureiro K, Reid TR, Ma JD.
    Future Oncol; 2008 Aug; 4(4):483-500. PubMed ID: 18684060
    [Abstract] [Full Text] [Related]

  • 7. Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues.
    Fumoleau P, Coudert B, Isambert N, Ferrant E.
    Ann Oncol; 2007 Jul; 18 Suppl 5():v9-15. PubMed ID: 17656562
    [Abstract] [Full Text] [Related]

  • 8. Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes.
    Yardley DA.
    Clin Breast Cancer; 2008 Dec; 8(6):487-92. PubMed ID: 19073502
    [Abstract] [Full Text] [Related]

  • 9. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA.
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of ixabepilone, a novel epothilone analogue.
    Pivot X, Dufresne A, Villanueva C.
    Clin Breast Cancer; 2007 Apr; 7(7):543-9. PubMed ID: 17509162
    [Abstract] [Full Text] [Related]

  • 11. The optimal therapeutic use of ixabepilone in patients with locally advanced or metastatic breast cancer.
    Boehnke Michaud L.
    J Oncol Pharm Pract; 2009 Jun; 15(2):95-106. PubMed ID: 19171553
    [Abstract] [Full Text] [Related]

  • 12. Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.
    Altmann KH, Memmert K.
    Prog Drug Res; 2008 Jun; 66():273, 275-334. PubMed ID: 18416309
    [Abstract] [Full Text] [Related]

  • 13. Development of other microtubule-stabilizer families: the epothilones and their derivatives.
    Brogdon CF, Lee FY, Canetta RM.
    Anticancer Drugs; 2014 May; 25(5):599-609. PubMed ID: 24398663
    [Abstract] [Full Text] [Related]

  • 14. Epothilones: clinical update and future directions.
    Donovan D, Vahdat LT.
    Oncology (Williston Park); 2008 Apr 15; 22(4):408-16; discussion 416, 421, 424 passim. PubMed ID: 18472615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
    Villanueva C, Dufresne A, Pivot X, Viel E.
    Bull Cancer; 2008 Feb 15; 95(2):197-204. PubMed ID: 18304905
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 15; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 18. Application of epothilones in breast cancer therapy.
    Cianfrocca M.
    Curr Opin Oncol; 2008 Nov 15; 20(6):634-8. PubMed ID: 18841044
    [Abstract] [Full Text] [Related]

  • 19. Ixabepilone, a new treatment option for metastatic breast cancer.
    Toppmeyer DL, Goodin S.
    Am J Clin Oncol; 2010 Oct 15; 33(5):516-21. PubMed ID: 20023567
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.